Moderna, Inc. (MRNA) Financial Statements
Moderna, Inc. (MRNA) reported trailing twelve-month revenue of $2.2B (down 27.6% year on year) and net income of -$3.2B as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$1.2B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MRNAModerna, Inc.Follow MRNA — free
—
Price chart with a free account
- Market cap
- 79.9B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 6 Nov, in 13 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.14 | 0.06 | 0.80 | 18.47 | 19.26 | 6.85 | 3.24 | 1.94 | 2.23 | |
| Gross profit | — | — | 0.80 | 15.85 | 13.85 | 2.16 | 1.77 | 1.08 | 0.52 | |
| Research & development | 0.45 | 0.50 | 1.37 | 1.99 | 3.30 | 4.85 | 4.54 | 3.13 | 2.88 | |
| Operating income | -0.41 | -0.55 | -0.76 | 13.30 | 9.42 | -4.24 | -3.95 | -3.07 | -3.32 | |
| Pre-tax income | -0.38 | -0.51 | -0.74 | 13.29 | 9.58 | -3.94 | -3.61 | -2.77 | -3.09 | |
| Income tax | 0.00 | -0.00 | 0.00 | 1.08 | 1.21 | 0.77 | -0.05 | 0.05 | 0.06 | |
| Net income | -0.38 | -0.51 | -0.75 | 12.20 | 8.36 | -4.71 | -3.56 | -2.82 | -3.15 | |
| Diluted EPS ($) | -4.95 | -1.55 | -1.96 | 28.29 | 20.12 | -12.33 | -9.28 | -7.26 | -7.99 | |
| Diluted shares (bn) | — | — | — | 0.431 | 0.416 | 0.382 | 0.384 | 0.389 | — |
USD billions · SEC XBRL
Moderna, Inc. — questions
- What is Moderna, Inc.'s revenue?
- $2.2B over the twelve months to 2026-06-30, down 27.6% year on year, from its 10-Q and 10-K filings.
- What is Moderna, Inc.'s net income?
- -$3.2B over the twelve months to 2026-06-30.
- What is Moderna, Inc.'s free cash flow?
- -$1.2B over the twelve months to 2026-06-30.
- What are Moderna, Inc.'s diluted earnings per share?
- $-7.99 over the twelve months to 2026-06-30.
Every figure on this page comes from Moderna, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.